SHENZHEN, China--(BUSINESS WIRE)--Tongjitang Chinese Medicines Company (NYSE: TCM - News), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today clarified that its Xiuwen plant ceased production for only two days following water-contamination problems related to the earthquake that struck Central China last week. The Company previously stated correctly that production resumed one week after the earthquake.
